Edwards profit up on strong sales of new heart valve

Feb 4 (Reuters) - Edwards Lifesciences Corp posted on Monday higher fourth-quarter earnings on strong sales of its artificial heart valve that is implanted in a less-invasive procedure than open-heart surgery.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.